ARK Investment Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,220,351
Closed -$1.09M 231
2023
Q2
$1.09M Sell
2,220,351
-85,235
-4% -$69.7K 0.01% 196
2023
Q1
$2.67M Sell
2,305,586
-456,528
-17% -$835K 0.02% 143
2022
Q4
$7.4M Sell
2,762,114
-2,706,711
-49% -$7.13M 0.06% 112
2022
Q3
$15.6M Sell
5,468,825
-2,953,599
-35% -$12.6M 0.11% 95
2022
Q2
$40.3M Buy
8,422,424
+121,085
+1% +$634K 0.24% 63
2022
Q1
$59M Buy
8,301,339
+294,904
+4% +$2.44M 0.25% 62
2021
Q4
$146M Sell
8,006,435
-496,481
-6% -$10.7M 0.44% 45
2021
Q3
$166M Buy
8,502,916
+1,599,707
+23% +$60.8M 0.4% 52
2021
Q2
$309M Buy
6,903,209
+1,787,217
+35% +$82.8M 0.58% 44
2021
Q1
$257M Buy
5,115,992
+3,651,475
+249% +$249M 0.51% 54
2020
Q4
$131M Buy
1,464,517
+1,378,185
+1,596% +$116M 0.35% 64
2020
Q3
$6.59M Buy
+86,332
New +$5.48M 0.04% 122

Other funds holding CELL

ARK Investment Management's CELL Position: Q3 2023 in Review

ARK Investment Management sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 2,220,351 shares — an estimated $1.09M sold.

ARK Investment Management first reported a position in CELL in Q3 2020 and held it in 12 quarters. The position peaked at $309M in Q2 2021. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • ARK Investment Management reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • ARK Investment Management sold 2,220,351 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $1.09M.
  • ARK Investment Management first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 12 quarters.
  • ARK Investment Management's PhenomeX Inc. Common Stock position peaked at $309M in Q2 2021.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on ARK Investment Management's 13F filing for Q3 2023, filed 18 Oct 2023.